iodamide has been researched along with Carcinoma, Hepatocellular in 6 studies
Iodamide: An ionic monomeric contrast medium. (From Martindale, The Extra Pharmacopoeia, 30th ed, p706)
iodamide : A benzoic acid compound having iodo substituents at the 2-, 4- and 6-positions, an acetamido substituent at the 3-position and an acetamidomethyl substituent at the 5-position.
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Faster growing hepatomas also have greater quantities of sulfhydryls and disulfides." | 1.25 | Sulfhydryl group quantitation of hepatoma and liver microsomal fractions. ( Hochberg, AA; Morris, HP; Stratman, FW; Zahlten, RN, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stratman, FW | 1 |
| Hochberg, AA | 1 |
| Zahlten, RN | 1 |
| Morris, HP | 1 |
| Sako, M | 5 |
| Hirota, S | 5 |
| Ohtsuki, S | 2 |
| Sakamoto, K | 1 |
| Hasegawa, M | 3 |
| Shimizu, T | 2 |
| Hase, M | 2 |
| Tanaka, K | 2 |
| Ueda, E | 1 |
| Fujita, Y | 1 |
| Kohno, M | 1 |
| Okuda, K | 1 |
| Watanabe, H | 1 |
| Kono, M | 1 |
6 other studies available for iodamide and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Sulfhydryl group quantitation of hepatoma and liver microsomal fractions.
Topics: Age Factors; Animals; Carcinoma, Hepatocellular; Cell Fractionation; Disulfides; Edetic Acid; Endopl | 1975 |
[Embolotherapy of hepatomas using ferromagnetic microspheres, its clinical evaluation and the prospect of its use as a vehicle in chemoembolo-hyperthermic therapy].
Topics: Animals; Antineoplastic Agents; Carboxymethylcellulose Sodium; Carcinoma, Hepatocellular; Dextrans; | 1986 |
Clinical evaluation of ferromagnetic microembolization for the treatment of hepatocellular carcinoma.
Topics: Carboxymethylcellulose Sodium; Carcinoma, Hepatocellular; Dextrans; Drug Combinations; Embolization, | 1986 |
[Transcatheter hepatic arterial embolization with embolic materials containing OK-432].
Topics: Animals; Biological Products; Carboxymethylcellulose Sodium; Carcinoma, Hepatocellular; Catheterizat | 1987 |
[Clinical studies on transcatheter arterial embolization in the treatment of hepatocellular carcinoma--analysis of different embolic materials for therapeutic effect and hepatic function reserve].
Topics: Adult; Aged; Carboxymethylcellulose Sodium; Carcinoma, Hepatocellular; Dextrans; Drug Combinations; | 1988 |
[Clinical evaluation of transcatheter arterial embolization in hepatocellular carcinoma--comparison of FME with GSE in terms of tumor factors].
Topics: Analysis of Variance; Carboxymethylcellulose Sodium; Carcinoma, Hepatocellular; Dextrans; Drug Combi | 1988 |